{
    "2019-05-22": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Array BioPharma Gains on Colorectal Cancer Study Success",
                "features": {
                    "keywords": [
                        "Array",
                        "BioPharma",
                        "Colorectal",
                        "Cancer",
                        "Study",
                        "Success"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-04-10",
                "original_text": "3 Tech Stocks for Growth Investors to Buy Right Now",
                "features": {
                    "keywords": [
                        "Tech",
                        "Stocks",
                        "Growth",
                        "Investors",
                        "Buy"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "technology"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-17",
                "original_text": "Eli Lilly says lower-priced insulin is now available",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "lower-priced",
                        "insulin",
                        "available"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-29",
                "original_text": "Merck to Buy Private Cancer Drugmaker Peloton Therapeutics",
                "features": {
                    "keywords": [
                        "Merck",
                        "Buy",
                        "Private",
                        "Cancer",
                        "Drugmaker",
                        "Peloton",
                        "Therapeutics"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biopharma"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "Lilly's Crohn's Disease Candidate Meets Phase II Study Goals",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Crohn's",
                        "Disease",
                        "Candidate",
                        "Phase",
                        "II",
                        "Study",
                        "Goals"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-10",
                "original_text": "Should We Worry About Eli Lilly and Company's (NYSE:LLY) P/E Ratio?",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "P/E",
                        "Ratio",
                        "Worry"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-09-20",
                "original_text": "Eli Lilly's Insulin Lispro Injection available at half the list price of Humalog",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Insulin",
                        "Lispro",
                        "Injection",
                        "half",
                        "price",
                        "Humalog"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-01",
                "original_text": "Lilly selling half-price version of popular Humalog insulin",
                "features": {
                    "keywords": [
                        "Lilly",
                        "selling",
                        "half-price",
                        "version",
                        "Humalog",
                        "insulin"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-15",
                "original_text": "Lilly's Lower-Priced Insulin Now Available",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Lower-Priced",
                        "Insulin",
                        "Available"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}